🔎 Trials Near Me

Akèy › Kansè kolon › Massachusetts › Boston

Etid klinik pou Kansè kolon nan Boston, MA

22 etid pou Kansè kolon ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Distance-Based Exercise to Preserve Function and Prevent Disability

Ap rekrite
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884

A Study of PHN-012 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1
  • PHN-012-001 Site, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Ap rekriteFaz 3
  • Brigham and Women's Hospital (BWH), Boston
  • Dana-Farber Cancer Institute (DFCI), Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Ap rekriteFaz 1/2
  • Massachusetts General Hospital - Main Campus, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Ap rekriteFaz 3
  • Massachusetts General Hospital, Boston
  • Oncura Health, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07284849

Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial

Ap rekrite
  • Dana Farber Cancer Institute, Boston
Laj 18 a 50 · Tout sèks · Mizajou Sep 11, 2026 · NCT06202183

Resilience and Equity in Aging, Cancer, and Health (REACH)

Ap rekrite
  • Dana-Farber Cancer Institute, Boston
Laj 65 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04674267

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Ap rekrite
  • Massachusetts General Hospital Cancer Center, Boston
Laj 45 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Ap rekriteFaz 2/3
  • Tufts Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05174169

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Ap rekriteEtid obsèvasyon
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT07675967

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Ap rekriteFaz 1
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Ap rekriteFaz 1
  • Research Site, Boston
  • Research Site, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Ap rekriteFaz 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • Massachusetts General Hospital,, Boston
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Ap rekriteFaz 1/2
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT05379985

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Ap rekriteFaz 1 bonè
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT02172651

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Ap rekriteEtid obsèvasyon
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT00843375

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06239194

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

Ap rekrite
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT05773144

Building Connections

Ap rekrite
  • Disparities Research Unit, Massachusetts General Hospital, Boston
Laj 18 a 75 · Tout sèks · Mizajou Nov 18, 2025 · NCT07091032

Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study

Ap rekriteVolontè an sante akeyi
  • Codman Square Health Center, Boston
  • East Boston Neighborhood Health Center, East Boston · 2 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT05524428

Etid Kansè kolon nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.